Literature DB >> 18607781

High frequency plasmid recombination mediated by 28 bp direct repeats.

Sofia C Ribeiro1, Pedro H Oliveira, Duarte M F Prazeres, Gabriel A Monteiro.   

Abstract

The stability in Escherichia coli of a mammalian expression vector (pCIneo) and its derivative candidate DNA vaccine (pGPV-PV) is described. These multicopy pMB1-type plasmids were found to recombine in several recA E. coli strains due to the presence of two 28 bp direct repeats flanking intervening sequences of 1.6 kb (pCIneo) and 3.2 kb (pGPV-PV). In this recombination event, one of the direct repeats and the intervening sequence were deleted or duplicated, originating monomeric or/and hetero-dimeric plasmid forms, respectively. Additionally, the plasmid rearrangement led to the acquisition of a kanamycin resistance phenotype. Recombination frequencies between 7.8 x 10(-7) and 3.1 x 10(-5) were determined for DH5alpha and JM109(DE3) strains, respectively. Higher recombination frequencies were found in cells previously grown up to stationary growth phase being the monomeric plasmid form the prevalent one. Real-time PCR quantification revealed the presence of approximately 1.5 x 10(4) recombined molecules per 2 x 10(5 )cells pre-kanamycin exposure. Under selective pressure of this antibiotic, the number of recombined molecules increased approximately 2,000-fold in a 48-h period replacing the original plasmid form. The high frequency, at which deletion-duplication occurred in the absence of kanamycin selective pressure, should be regarded as a safety concern. This work highlights the impact of mutational hot spots on expression and cloning plasmid vectors and the need to carefully design plasmid vectors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18607781     DOI: 10.1007/s12033-008-9082-3

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  32 in total

1.  Creation of genome-wide protein expression libraries using random activation of gene expression.

Authors:  J J Harrington; B Sherf; S Rundlett; P D Jackson; R Perry; S Cain; C Leventhal; M Thornton; R Ramachandran; J Whittington; L Lerner; D Costanzo; K McElligott; S Boozer; R Mays; E Smith; N Veloso; A Klika; J Hess; K Cothren; K Lo; J Offenbacher; J Danzig; M Ducar
Journal:  Nat Biotechnol       Date:  2001-05       Impact factor: 54.908

2.  Mutator bacteria as a risk factor in treatment of infectious diseases.

Authors:  Antoine Giraud; Ivan Matic; Miroslav Radman; Michel Fons; François Taddei
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 3.  Encoded errors: mutations and rearrangements mediated by misalignment at repetitive DNA sequences.

Authors:  Susan T Lovett
Journal:  Mol Microbiol       Date:  2004-06       Impact factor: 3.501

4.  Optimized expression vector for ion channel studies in Xenopus oocytes and mammalian cells using alfalfa mosaic virus.

Authors:  Srinivasan P Venkatachalan; Jeremy D Bushman; José L Mercado; Feyza Sancar; Kelly R Christopherson; Andrew J Boileau
Journal:  Pflugers Arch       Date:  2006-12-05       Impact factor: 3.657

5.  Mechanisms of deletion formation in Escherichia coli plasmids. II. Deletions mediated by short direct repeats.

Authors:  A V Mazin; A V Kuzminov; G L Dianov; R I Salganik
Journal:  Mol Gen Genet       Date:  1991-08

6.  Molecular mechanisms of deletion formation in Escherichia coli plasmids. I. Deletion formation mediated by long direct repeats.

Authors:  G L Dianov; A V Kuzminov; A V Mazin; R I Salganik
Journal:  Mol Gen Genet       Date:  1991-08

Review 7.  Replication fork stalling at natural impediments.

Authors:  Ekaterina V Mirkin; Sergei M Mirkin
Journal:  Microbiol Mol Biol Rev       Date:  2007-03       Impact factor: 11.056

8.  Recombination frequency in plasmid DNA containing direct repeats--predictive correlation with repeat and intervening sequence length.

Authors:  Pedro H Oliveira; Francisco Lemos; Gabriel A Monteiro; Duarte M F Prazeres
Journal:  Plasmid       Date:  2008-08-03       Impact factor: 3.466

9.  DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses.

Authors:  C Bahloul; Y Jacob; N Tordo; P Perrin
Journal:  Vaccine       Date:  1998-02       Impact factor: 3.641

10.  A replicational model for DNA recombination between direct repeats.

Authors:  X Bi; L F Liu
Journal:  J Mol Biol       Date:  1996-03-15       Impact factor: 5.469

View more
  6 in total

1.  Mapping Protein-Protein Interaction Interface Peptides with Jun-Fos Assisted Phage Display and Deep Sequencing.

Authors:  Wanzhi Huang; Victoria Soeung; David M Boragine; Timothy Palzkill
Journal:  ACS Synth Biol       Date:  2020-06-23       Impact factor: 5.110

Review 2.  Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.

Authors:  James A Williams; Aaron E Carnes; Clague P Hodgson
Journal:  Biotechnol Adv       Date:  2009-02-20       Impact factor: 14.227

3.  Generic plasmid DNA production platform incorporating low metabolic burden seed-stock and fed-batch fermentation processes.

Authors:  James A Williams; Jeremy Luke; Sarah Langtry; Sheryl Anderson; Clague P Hodgson; Aaron E Carnes
Journal:  Biotechnol Bioeng       Date:  2009-08-15       Impact factor: 4.530

Review 4.  The Five Immune Forces Impacting DNA-Based Cancer Immunotherapeutic Strategy.

Authors:  Suneetha Amara; Venkataswarup Tiriveedhi
Journal:  Int J Mol Sci       Date:  2017-03-17       Impact factor: 5.923

5.  Adaptive laboratory evolution accelerated glutarate production by Corynebacterium glutamicum.

Authors:  Carina Prell; Tobias Busche; Christian Rückert; Lea Nolte; Christoph Brandenbusch; Volker F Wendisch
Journal:  Microb Cell Fact       Date:  2021-05-10       Impact factor: 5.328

6.  A principle of organization which facilitates broad Lamarckian-like adaptations by improvisation.

Authors:  Yoav Soen; Maor Knafo; Michael Elgart
Journal:  Biol Direct       Date:  2015-12-02       Impact factor: 4.540

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.